Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.541, 2007-01, pp. : 8-8
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Insulin glargine better value than NPH in T2DM
Inpharma, Vol. 1, Iss. 1613, 2007-01 ,pp. :
Access to resources
Recommend
Insulin glargine superior long-term therapy for type 2 DM in Europe
Inpharma, Vol. 1, Iss. 1457, 2004-01 ,pp. :
Insulin glargine superior long-term therapy in type 2 DM in Europe
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 462, 2004-01 ,pp. :
Add-on insulin glargine enhances HRQOL in type 2 DM
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 490, 2005-01 ,pp. :
Insulin: basal-bolus more cost effective than premixed for T2DM
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 634, 2011-01 ,pp. :